International Journal of
Environmental Research
and Public Health
Perspective
Telemedicine and Haemodialysis Care during the COVID-19
Pandemic: An Integrative Review of Patient Safety, Healthcare
Quality, Ethics and the Legal Considerations in
Singapore Practice
Sabrina Haroon 1, *, Teck Chuan Voo 2 , Hillary Chua 3 , Gan Liang Tan 4 and Titus Lau 1
1
2
3
4
*
Citation: Haroon, S.; Voo, T.C.; Chua,
H.; Tan, G.L.; Lau, T. Telemedicine
and Haemodialysis Care during the
COVID-19 Pandemic: An Integrative
Review of Patient Safety, Healthcare
Quality, Ethics and the Legal
Considerations in Singapore Practice.
Int. J. Environ. Res. Public Health 2022,
19, 5445. https://doi.org/10.3390/
ijerph19095445
Academic Editor: Giulio Nittari
Division of Nephrology, National University Hospital Singapore, Singapore 119228, Singapore;
titus_lau@nuhs.edu.sg
Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore,
Singapore 117597, Singapore; mdvtc@nus.edu.sg
Faculty of Law, National University of Singapore, Singapore 259776, Singapore; h_chua@nus.edu.sg
Department of General Medicine, Sengkang General Hospital, Singapore 544886, Singapore;
tan.gan.liang@singhealth.com.sg
Correspondence: sabrina_haroon@nuhs.edu.sg
Abstract: The COVID-19 pandemic has been an unprecedented health crisis for the general population
as well as for patients with chronic illnesses such as those requiring maintenance dialysis. Patients
suffering from chronic kidney disease requiring dialysis are considered a high-risk population.
Multiple reports have highlighted an increased need for intensive care and higher death rates among
this group of patients. Most maintenance dialysis patients are in-centre haemodialysis patients
who receive treatment in shared facilities (community dialysis centres). The inability to maintain
social distancing in these facilities has led to case clustering among patients and staff. This poses a
substantial risk to the patients, their household members, and the wider community. To mitigate the
risks of COVID-19 transmission, telemedicine was rapidly adopted in the past year by nephrologists
and other allied-health staff to provide care via remote consultations and reviews. Telemedicine
poses unique challenges even in an era where so much is performed online with a high degree of
success and satisfaction. In applying distant clinical care for maintenance haemodialysis patients via
telemedicine, there is a need to ensure adequate protection for the health and safety of patients as
well as understand the ethical and legal implications of telemedicine. We discussed, in this article,
these three core aspects of patient safety and quality, ethics and legal implications in telemedicine,
and how each of these is crucial to the safe and effective delivery of care in general as well as unique
aspects of this in Singapore.
Received: 28 March 2022
Accepted: 27 April 2022
Published: 29 April 2022
Keywords: telemedicine; haemodialysis; COVID-19
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
1. Introduction
iations.
Telemedicine is a well-established care delivery format in today’s health services
structure [1]. Telemedicine is generally defined as the assessment of health, diagnosis,
treatment, interventions, or any health-related care activities that are provided over a
distance using info-communication technology [2]. It was first intended to provide better
and easier healthcare access to remote (usually small) populations [3,4]. Later, as technology
matured and mindsets shifted, the adoption of telemedicine became more widespread and
was no longer restricted to areas that were hard to reach [5]. It has since evolved to become
a complementary option of care delivery that fulfils many important key measures of
healthcare services such as optimised efficiency, increased convenience, and cost lowering
without compromising patient safety and satisfaction [6,7]. Over the years, and especially
in the last decade, there has emerged an even broader umbrella of digital healthcare
Copyright: © 2022 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
Int. J. Environ. Res. Public Health 2022, 19, 5445. https://doi.org/10.3390/ijerph19095445
https://www.mdpi.com/journal/ijerph
Int. J. Environ. Res. Public Health 2022, 19, 5445
2 of 13
solutions known as technology-enhanced care that offers even more possibilities [8]. The
advancement of electronic and mobile technologies has made possible the implementation
of telemedicine in many fields of medicine [9]. The adoption of technology has permitted
care to be delivered more efficiently and effectively in the home environment and removed
the dependence on health facilities.
In addition to its adoption as part of day-to-day healthcare, telemedicine has useful
applications as a disaster response tool [10]. There are several categories of health applications in disaster response, including ambulatory and primary care, specialty consultation,
remote monitoring, triaging, and medical logistics coordination. Telemedicine is described
as a force multiplier, providing medical and public health expertise at a distance, and
minimizing the logistic and safety issues associated with on-site care provision [11]. A
telehealth white paper prepared by a telehealth think tank group from the Office for the
Advancement of Telehealth, Health Resources and Services Administration in the United
States elaborated on the strategic applications and challenges of how telemedicine can be
an effective component of disaster response. The group concluded with recommendations
that include shifting mindsets, integrating telemedicine into disaster response plans, developing an inventory of telehealth resources and protocols, provision of necessary telehealth
equipment and software, and hardening telehealth networks to ensure reliability [11].
Logically, telemedicine is also ideal for managing a global infectious disease pandemic.
It has several key qualities that effectively enhance the emergency response during an
infectious disease outbreak such as the current COVID-19 pandemic. A key factor in
slowing the transmission of an infectious pathogen is “social distancing” to decrease personto-person contact. Telemedicine can perform remote triaging of care, assist in diagnosis
via video consultations and testing, provide care for those who are infected, disseminate
public advice and education, and serve as a tool to coordinate and deliver routine medical
care [12]. The implementation of telemedicine during the ongoing COVID 19 pandemic
was not only restricted to first-world economies in North America and Europe but lowerresource countries such as Africa, Latin America, the Middle East, and Asia [9,13]. These
countries have utilized telemedicine for COVID-19-related and non-COVID-19-related
medical conditions in their health services. All of them reported satisfactory outcomes, and
telemedicine generally benefitted the population.
In Singapore, as elsewhere, the COVID-19 pandemic has accelerated the adoption of
telemedicine nationwide [14]. In 2020, at the height of the pandemic, strategic measures
were taken to escalate various domains of telemedicine, particularly telemonitoring and
telesupport. These include tools such as the Singapore COVID-19 Symptom Checker,
where artificial intelligence is used to advise users on their next course of action should
they experience the symptoms listed in the application. The “Flu Go Where” microsite
advises those who meet the criteria for COVID-19 screening on the location of the nearest
clinic. A group in Bern, Switzerland, has also recently published a framework for online
forward triaging and cited seven criteria that will ensure the adequacy of the tool used
for this purpose [15]. In terms of pharmaceutical logistics, a similar service, the “Mask Go
Where” webpage, advised on mask distribution. In contrast, medication delivery services
were ramped up to deliver medication nationwide, avoiding queues and healthcare facility
visits. Every adult resident received a complimentary pulse oximeter to monitor oxygen
saturation, and telekiosks for video consultations were made available as part of a broader
comprehensive health support plan [16]. Telemedicine was also deployed in managing
infected patients at community care facilities and community recovery facilities [17,18].
Towards late 2021, more than 80% of the Singapore population were fully vaccinated, and
many of those infected had very mild diseases and were successfully managed at home
using teleconsult and telemonitoring [19].
As part of the overall COVID-19 management strategy, Singapore’s Ministry of Health
(MOH) encouraged the use of telemedicine for all “non-essential” healthcare services in
order to reduce hospital workloads and promote safe distancing [20]. Dialysis services
were deemed essential, but the treatment of other renal diseases with no active or recurrent
Int. J. Environ. Res. Public Health 2022, 19, 5445
3 of 13
symptoms was classified as “non-essential” and suitable for teleconsultation [21]. Dialysis
services generally encompass two broad areas—the dialysis treatment that is conducted at
the facility and the care and review of dialysis patients. In-centre haemodialysis (ICHD) will
require patient attendance at the facility, but the clinical review of ICHD patients is an activity that can potentially be conducted off-site via telemedicine. One of the main infection
control measures at the start of the pandemic was to control the movement of healthcare
professionals to minimise potential exposure and spread. This article describes the transition and structure of providing care to ICHD patients in Singapore via telemedicine
platform and shares our insights on this model of remote care from the perspective of
clinical quality, ethical standards, and legal considerations.
2. Management of ICHD Patients
Singapore has seen an increasing number of renal failure patients over the years. The
Singapore Renal Registry registered 8211 prevalent dialysis patients in 2020 [22]. Most of
the patients (86%) are ICHD patients receiving haemodialysis treatments from over 100
satellite dialysis units in Singapore [22]. These are either charity-funded units or private
for-profit units. The management of ICHD patients in Singapore generally involves two
nephrologists. The dialysis centre nephrologist is tasked with ensuring that patients in a
particular centre are doing well and managed optimally. Hence, it is mandatory that all
ICHD patients are reviewed at least once a month at the dialysis centre [23]. The primary
nephrologist at the hospital complements the monthly (shorter) review and sees the patient
at the clinic (when the patient is not on dialysis) for a lengthier consult to have an in-depth
discussion and a detailed physical examination. The typical schedule is every four to six
months (Figure 1). Given this structure of practice, both will jointly manage the patients
and exchange management decisions via email or phone call.
Figure 1. Structure of review at the dialysis unit before the COVID-19 pandemic.
The dialysis centre nephrologist will review the patient while the patient is on haemodialysis (HD) treatment, focusing on more immediate dialysis issues (such as access to health,
fluid, and blood pressure management, anaemia correction, and metabolic bone disorder).
Physical examination is brief and mainly focused on volume assessment or other simple examinations that can be done with the patient seated on a recliner chair. A detailed physical
examination is difficult to conduct, given that ideal positioning and manoeuvres are not
possible while on dialysis. Other limitations of a review conducted during HD treatments
are that some patients may be symptomatic on dialysis, with multiple ongoing alarms and
proximity to the next patient in an open cubicle. Therefore, some of the clinical problems
cannot be fully addressed. These unresolved clinical issues and other discussions are then
During the
initial
phase of
the pandemic
in hospital.
Singapore,
including
the “circuit
breaker”
referred
to their
primary
nephrologist
at the
Patients
will have
more privacy
in pethe
bility or “R Naught” was not entirely clear. As such, many satellite dialysis centres incor-
Int. J. Environ. Res. Public Health 2022, 19, 5445
4 of 13
consulting room and when a detailed physical examination can be performed. Despite the
stated limitations, dialysis centre reviews are still a very effective adjunct to care for these
patients as it does not require travel or frequent additional costly hospital appointments.
3. Conduct of Dialysis Review via Telemedicine
Telemedicine has been widely used in managing home dialysis patients in many parts
of the world (both home haemodialysis and peritoneal dialysis) [24,25]. MOH Singapore
has published the National Telemedicine Guidelines (2015) for local healthcare practice [26].
However, there is no specific guidance for telemedicine at the dialysis centre. As a result,
the use of telemedicine in satellite dialysis centres had been limited until the COVID-19
pandemic necessitated a change in approach. The small geographical footprint of this
island-state and the long-held tradition that in-person review is the standard of care have
also largely contributed to this lack of adoption of telemedicine in ICHD care. During
the initial phase of the pandemic in Singapore, including the “circuit breaker” period (i.e.,
a nationwide partial lockdown), vaccines were non-existent, and the transmissibility or
“R-Naught” was not entirely clear. As such, many satellite dialysis centres incorporated
telemedicine as part of dialysis care to reduce the need for physical review by the nephrologist. Given the different types of patient reviews and intended purpose, telemedicine is
used primarily to replace the monthly in-person review at the dialysis centre. It should
be noted that most of our local nephrologists have multiple sites of practice that include a
hospital and more than one satellite dialysis centre (usually up to four centres). In-person
nephrologist visits to the satellite dialysis centres may still inadvertently lead to outbreaks
arising from interactions between the nephrologists, staff, and patients at the centre. However, there are strict infection control measures, including the use of full personal protection
equipment (PPE).
As the COVID-19 outbreak has entered into an endemic phase in recent months,
restrictions on the movement of healthcare professionals between healthcare facilities have
been reduced. However, telemedicine is still favoured by some to reduce the frequency of inperson physician reviews at the dialysis centre. Most dialysis centres have a fixed schedule
for blood and adjunct tests such as bioimpedance and vascular access flow monitoring that
is performed every two months. The nephrologist will usually perform a physical in-person
round during blood test month as there are often discussions about medications, referrals,
and various changes. Telemedicine review is then conducted on non-blood test months,
with the option to alternate between physical reviews at the dialysis centre. In addition
to these reviews, the primary nephrologist will continue to have in-person consults at the
hospital’s clinic (Figure 2).
Figure 2. Structure of review at the dialysis unit since onset of the COVID-19 pandemic.
Int. J. Environ. Res. Public Health 2022, 19, 5445
5 of 13
4. Ensuring Patient Safety and Maintaining Care Quality
The COVID-19 pandemic has certainly challenged many healthcare systems. To
respond to the crisis, these systems have had to reorganise instantly, risking possible threats
to patient safety, and compromising the quality of care [27,28]. As we increase our reliance
on telemedicine during the COVID-19 pandemic, we must also be cognisant of the potential
gaps that may exist. New technologies and care models come with attendant risks [29].
Healthcare systems adopting telemedicine should focus on pre-emptive risk reduction with
adequate planning and emphasis on details. There are seven key elements as described by
Vincent that influence patient safety, and these should be taken into consideration when
adopting telemedicine [30]. The components within each of these elements related to the
conduct of ICHD rounds via telemedicine are shown below (Figure 3).
Figure 3. Core elements of patient safety while adopting telemedicine.
Telemedicine for the review of ICHD patients in Singapore takes the form of real-time
interactive video conferencing between the nephrologist, the dialysis centre nurse, and the
patient. As there are no established telemedicine platforms amongst dialysis providers in
Singapore, most choose to use Zoom, a commercial third-party video conferencing platform
d
that was not specifically designed for healthcare use. It was simple to use but with few
enhanced features to support better clinical review of patients. Some nephrologists also
adopted the “store and forward” method of telemedicine by getting the dialysis centre to
send relevant data that is usually needed for the review of ICHD patients, such as dialysis
treatment charts, recent laboratory results, and measurements done at the dialysis centre.
The live teleconsult would be scheduled soon after such information had been obtained
and reviewed by the nephrologist. Some dialysis providers have a software system that
allows the nephrologist to access the system and view relevant information directly. Others
who do not follow this pattern of practice will review all patient information during the
live teleconsult (with the attending nurse updating the nephrologist).
One critical aspect of care for HD patients is maintaining dialysis access. In our
effort to reduce direct physical examination during the pandemic, telemedicine is a useful
Int. J. Environ. Res. Public Health 2022, 19, 5445
6 of 13
alternative for access evaluation. Findings of aneurysms, infections, depigmentation, skin
thinning, ulcerations, oedema, and catheter exit site issues can all be detected remotely [31].
Supplementary information relevant to access patency (such as access flow measurement,
arterial and venous pressure changes during treatment, stability of prescribed blood flow)
can be easily captured and transmitted via electronic means [32].
It is crucial to understand that telemedicine will not entirely reduce the acquisition
or transmission of COVID-19. However, it does help mitigate the risk along with many
other appropriate infection control measures. Hence, it is a positive effort toward patient
safety. In adopting telemedicine, we need to ensure no compromise on patient care by
omitting the in-person physical review [33]. The standard of care and expected tasks must
be fully accomplished. There should be sufficient time allocated for the nephrologist, staff,
and patient to deal with problems usually addressed during physical rounds. Most of
the evaluation, such as routine blood tests, dialysis parameters, medication lists, vascular
access measurement, and bioimpedance, can be reviewed either using an online dialysis
software or through the transfer of data. What is important is to ensure that the information
provided for a teleconsult is what is otherwise provided for an in-person physical review.
The data should be made fully available to the nephrologist and presented in the same
way that is easily interpretable by the nephrologist performing the teleconsult. Further,
there should be an established process workflow to document the review (via telemedicine)
for the healthcare team to follow up on any changes. To reduce the risk of missing any
clinical findings that otherwise would have been detected during physical rounds, dialysis
nurses can receive additional targeted education and training on simple examinations [34].
Suppose the patient is unwell and requires a physical review for better assessment. In
that case, rapid coordination of care using a mutually agreed pathway with the primary
nephrologist must be in place and escalation protocols established.
Beyond the clinical processes required to deliver high-quality care, the infrastructure
needed to make this possible cannot be undermined. Access to a robust and effective digital
infrastructure is critical in the delivery of care via telemedicine. In the context of Singapore’s
ICHD telemedicine initiative, a laptop with a high-quality audio-visual function was the
main device for connecting the nephrologist with the patient at the dialysis centre. There
were times when a tablet or a mobile device was used when a laptop was not available.
Ideally, the hardware must be tested before implementation to ensure sufficient clarity for
a teleconsult to take place. A specially designed software package that fits dialysis care
or a software system that integrates with the hospital’s electronic health record would
be advantageous. However, this was not possible in Singapore at the time of adoption
due to the rapidity of emergent adoption in this situation. The stability and bandwidth
for transmission are generally excellent in Singapore and do not pose a problem. The
infrastructure for telemedicine must be available when needed, and equally, the technology
must be reliable and secure, as is discussed further in the “Cybersecurity and Data Privacy”
section below.
As telemedicine in the ICHD setting is new to local practice, the monitoring of various aspects of care will be necessary to ensure satisfactory clinical outcomes and the safe
delivery of care (Table 1). One preliminary study involving the largest charity dialysis
organisation in Singapore reported that telemedicine was a successful tool for physician
oversight under movement control measures implemented during the COVID-19 pandemic. There was no increase in hospitalisation or mortality after the implementation of
telemedicine as a remote form of patient review [35]. Despite this encouraging report, there
is still a need to evaluate the workflow and make further adaptations. Apart from the
clinical outcome (as published), monitoring of safety and quality should follow the Donabedian model that categorises a healthcare system into structure, process, and outcome
(Figure 3). Incidents can be reduced by designing new processes with a focus on human
factor engineering principles, coupled with frequent evaluations during the initial phase
and to implement suggested changes. An example commonly used is the PDSA cycle,
Plan-Do Study Act [36]. When an adverse event or a near miss occurs, a rapid cycle root
Int. J. Environ. Res. Public Health 2022, 19, 5445
7 of 13
cause analysis or concise incidence analysis should be conducted soonest to improve the
structure or process [37].
Table 1. Quality measures telemedicine in dialysis unit in the Singapore setting.
Quality Measures
Structure
Number of review per year (physical and telemedicine)
Process
Staff satisfaction
Patient satisfaction
Outcome
Hospitalization rate after adoption of telemedicine
Hospitalization numbers from fluid overload
Given that this may involve a significant change in the structure and processes, understanding staff and patient satisfaction will be necessary [38,39]. Patient satisfaction is
part of patient-centric care that is championed as one of the aspirational core values of
the healthcare system in Singapore. Staff satisfaction is also essential as it does have a
significant association with quality of care. The quality indicators for outcome monitoring
should include hospital admissions and specifically for fluid overload, as volume excess is
usually diagnosed during the physical review. Other issues resulting in hospital admission
should be reviewed. In addition, an effort made to identify if any of the admissions can
be avoided if a physical review was performed in place of the teleconsult. Specific to our
local context, over time, we aim to determine the appropriate mix of physical reviews and
teleconsults to ensure that the care of our ICHD patients is not compromised [40].
5. Ethical Considerations and Justifications
The ethicality of introducing or increasing the reliance on telemedicine in the management and care of ICHD patients during a pandemic like COVID-19 depends on whether it
would help achieve public health goals. The section on telemedicine in the 2016 edition
of the Singapore Medical Council Ethical Code and Ethical Guidelines (ECEG) provides
guidance for the responsible provision of telemedicine. However, it does not elaborate
on its use in the context of a healthcare crisis [41]. At the beginning of the pandemic,
there were many scientific unknowns. As a result, it was hard to assess the extent to
which telemedicine, as a mode of physical distancing between physicians and patients,
would help to reduce spread, prevent mortality and morbidity, or reduce the strain on the
health system by protecting healthcare workers. Nevertheless, the use of telemedicine, in
conjunction with other public health measures (as mentioned above), is justifiable by the
precautionary principle [42], which directs policymakers to introduce measures to protect
populations against reasonably foreseeable serious risks in the absence of absolute certainty.
Proportionality [43] is another important consideration: the anticipated public health
benefits that accrue from the intervention should be proportionate, that is, significantly
outweigh the expected burdens, costs, and harms to patients as well as to the health system.
Singapore is one of the most wired and digitally inclusive countries in the world with a
highly advanced information and communication technology (ICT) infrastructure [44,45].
Thus, the implementation of teleconsults in satellite dialysis centres should not result in
significant burdens on its health system, or on patients, especially for those whom online
interactions have become a norm in many parts of their lives during the pandemic. As
discussed earlier, there is a need to mitigate harm to patients by ensuring that telemedicine
does not displace any necessary physical review. Such harm mitigation may be further
secured by guidelines on the minimum frequency for which patients on maintenance
dialysis ought to receive a physical review. Setting this minimum standard would also
promote equity in terms of patient outcomes. Other than these considerations, the ethical
acceptability of telemedicine for ICHD patients should also be guided by beneficence.
It may be important for some patients to have more face-to-face encounters with their
nephrologists to establish or maintain trust and a therapeutic doctor-patient relationship.
Int. J. Environ. Res. Public Health 2022, 19, 5445
8 of 13
Some patients may also face challenges engaging physicians during teleconsult due to their
particular conditions (e.g., hearing impairment) [46]. Insofar as public health would not
be compromised, these patients should be granted access to more in-person contact with
physicians to ensure that their care is optimised.
This raises the question of the extent to which telemedicine, as a public health response
to a pandemic, should be guided by a patient- or person-centred approach. The deployment
of telemedicine to reduce risks of transmission and infection means that it cannot be highly
tailored to the needs and preferences of individual patients. Respect for persons—as a core
principle of patient-centred care—can be observed in other ways. This includes protecting
patient privacy and the confidentiality of their medical information. As a function of respect
for persons, patients should also be informed of the benefits and risks of telemedicine
during the pandemic and the accompanying measures to ensure patient safety and care
quality, which would also promote patient trust and acceptability of this modality of care.
Failing to provide material information on telemedicine to patients would also have legal
implications under the law of negligence, as discussed below.
As Singapore moves towards COVID-19 resiliency by achieving high population
vaccination coverage and other public health responses, telemedicine may no longer be
a necessary measure to mitigate public health risks. As has been argued, it is likely the
case that health systems will continue to rely on telemedicine for ICHD patients and other
patient groups because of its advantages for patients in terms of “flexibility, benefits and
cost-saving” [47]. Compared to telemedicine for home dialysis patients, the advantages of
telemedicine in these aspects for patients receiving treatment at dialysis centres are less
clear. The ethical justification of telemedicine in a post-pandemic world largely depends on
the balance of benefits for physicians (for example by reducing the frequency of physical
reviews) the health system, and the benefits and potential harms for patients who could be
assessed by both monitoring and relevant research on patient outcomes.
6. Regulatory and Legal Requirements
In a review of telemedicine frameworks across the globe during the COVID-19 pandemic, Singapore was identified as a “front-runner in Asia in terms of telemedicine adoption
and healthcare system efficiency” [48]. This section provides an overview of Singapore’s
laws, regulations, and guidelines regarding the use of telemedicine, as an example of
how a national legal framework can bolster telehealth implementation and reinforce the
recommended practices in patient safety and medical ethics that were discussed above.
First, MOH Singapore will be introducing a set of telemedicine regulations under the
Healthcare Services Act 2020, which are expected to come into force at the end of 2023 [49].
This comes as part of a nationwide transition from a premises-based licensing regime
to a services-based licensing regime for healthcare providers [50]. Second, the National
Telemedicine Guidelines (2015) (NTG) stipulated the best practices for telemedicine services
in four broad domains: clinical standards and outcomes, human resources, organisation,
and technology and equipment [26]. Although the NTG has no force of law, MOH Singapore
may decide to sanction a healthcare provider for non-compliance with the NTG [50]. The
guidelines contain two key principles: (i) the overall standard of care for telemedicine must
not be any less than what is provided in face-to-face services, and (ii) where a face-to-face
consultation is not reasonably practical. Telemedicine is better than having no access to
care at all. Third, telehealth products are regulated under the Health Products Act 2007.
There are also official guidelines for telehealth products and artificial intelligence (AI) in
healthcare [51,52]. Separate regulations and guidelines apply to telepharmacy [53,54].
Singapore has a clear framework for accountability and disciplinary action in relation
to the use of telemedicine. This is in line with recommendations from the World Health
Organization regarding strategies for implementing telemedicine during the COVID-19
pandemic and beyond [55]. In terms of medical professional ethics, the ECEG states that
in telemedicine, physicians must endeavour to provide the same quality and standard
of care as in-person medical care [41]. It is important for physicians to be aware of the
Int. J. Environ. Res. Public Health 2022, 19, 5445
9 of 13
principles of the ECEG concerning the responsible use of telemedicine and upholding
patient confidentiality. A breach of the ECEG could result in disciplinary sanction for
professional misconduct under the Medical Registration Act 1997 [56]. For example, one key
principle in the ECEG states that physicians “must give patients sufficient information about
telemedicine for them to consent to it” [41]. Therefore, it would be helpful to anticipate
the limitations of using telemedicine for patient care (e.g., technological malfunctions or
diagnostic limitations) and design standardised consent forms accordingly [57]. This could
be supplemented with training and protocols for identifying which patients are suitable for
teleconsultation and should cover escalation procedures to in-person care [57,58].
When diagnostic or treatment errors occur from telemedicine, the Singapore courts will
assess whether the actions of the doctor in question can be supported by a responsible body
of expert opinions that satisfies a threshold test of logic [59–61]. If so, the doctor will not be
found negligent. However, suppose errors occur partly as a result of clinical negligence
and also technological malfunction. In that case, the apportionment of liability between a
clinician and a telehealth company (such as a software developer or manufacturer) will
depend on the facts of each case [50]. A physician may remain liable for overseeing the
choice and use of a telehealth modality even if technology is primarily to blame [52,62].
Regarding liability for not obtaining a patient’s informed consent, the Singapore courts will
assess whether the physician disclosed “relevant and material” information to the patient
about telemedicine, including risks and reasonable alternatives. What is “relevant and
material” will be determined with reference to what the “reasonable patient” and “specific
patient” would want to know [63]. Once Section 37 of the Civil Law (Amendment) Act
comes into force, it will amend the law such that expert medical opinion shall be used to
determine whether the standard for information disclosure has been met [64].
7. Cybersecurity and Data Privacy
Cybersecurity is an important consideration that has implications for patient safety,
ethics, and the law. Data privacy and protection have been identified as a core challenge
and critical factor for the success of telemedicine, which warrants a special discussion of
this topic [65]. In the United States, the Office for Civil Rights at the Department of Health
and Human Services issued a Notification of Enforcement Discretion for telehealth during
the COVID-19 nationwide public health emergency. This has allowed American healthcare
providers to provide telehealth services over platforms such as Skype and Zoom in good
faith without facing penalties for violating regulatory requirements under the Health
Insurance Portability and Accountability Act of 1996 (HIPAA) Rules [66]. In Singapore,
there is no equivalent relaxation of data protection laws for telemedicine specifically, so
healthcare providers should be mindful of the following rules.
The ECEG states that physicians “must take reasonable care to ensure confidentiality of
medical information shared through technology and ensure compliance with any applicable
existing legislation and regulations governing personal data” [41]. This would involve
complying with cybersecurity protocols and choosing a reasonably secure third-party
telemedicine platform. System vulnerabilities may result in inappropriate access to patient
information, medical device malfunction, or a breakdown in healthcare services provided
over remote communication platforms. These breaches can have profound effects on patient
safety and care. Moreover, the principle of respect for persons is a further reason for giving
due consideration to data security and protection regarding the online transmission or
sharing of medical information.
On an organisational level, the Personal Data Protection Act 2012 requires healthcare
providers to (i) obtain consent from patients to the collection, use, or disclosure of their
personal data, unless a recognised exception applies; and (ii) make reasonable security
arrangements to protect the data from unauthorised access, among other things [67]. Although there is an “Emergency Response Exemption” for the collection, use, and disclosure
of personal data without consent for contact tracing and other COVID-19 response measures, the need to make reasonable security arrangements to protect personal data still
Int. J. Environ. Res. Public Health 2022, 19, 5445
10 of 13
applies [68,69]. In 2019, the Personal Data Protection Commission (PDPC) issued fines
totalling SGD $1,000,000 against two public health bodies for lax cybersecurity measures,
which had resulted in hackers accessing the medical data of 1.5 million patients. In its
decision, the PDPC noted that medical data is “of a sensitive nature” and requires a higher
standard of protection [70]. Details of recommended cybersecurity measures and policies
for healthcare providers can be found in MOH Singapore’s Healthcare Cybersecurity Essentials Guidelines (2021) and AI in Healthcare Guidelines [52]. Section 27 of the Healthcare
Services Act 2020 also requires licensed healthcare providers to implement prescribed safeguards to protect medical records from unauthorised access. Failure to do so is a criminal
offence. Additionally, the use of telemedicine comes with a risk of identity fraud, such as
when third parties masquerade as patients through the use of manipulated videos known
as deepfakes. Therefore, it would be prudent to verify patients’ identities at the outset of
each teleconsult, using methods such as two-factor authentication [71]. The introduction of
telemedicine should not raise additional privacy concerns relative to physical rounds in
dialysis centres.
Many of the above considerations are mitigated by the manner in which telemedicine
is conducted for ICHD patient care. Existing patients are already known to the nephrologist,
and new patients are all registered formally and known to be actual patients undergoing
dialysis treatment. Data transfers are securely done via an independent platform (from
that used for teleconsultations), and all files are locked with a unique password to prevent
unauthorised access. The teleconsult is supervised on the patient’s side, and this is helpful in ensuring clarity of the exchanges as well as follow-up on the prescribed changes.
Telemedicine used in ICHD is expected to pass the same level of legal scrutiny as any other
telemedicine services in healthcare.
8. Conclusions
Telemedicine is certainly feasible and can be impactful in many ways. While it is
true that the use of telemedicine in the treatment plan of outpatient dialysis patients
in Singapore was born out of necessity due to the worldwide COVID-19 crisis, it has
accelerated a serious discussion regarding the possible sequelae of telemedicine—both
positive and negative. Professionally, we must strive to maintain a high standard of care
that prioritises patient safety and clinical efficacy. A patient-physician encounter is not
simply a means to complete a clinical task or solve a health issue, but it is a relationship
that is deeply intimate. Hence, there still exists a distinct emotive difference between a
virtual reality interaction and a face-to-face interaction. Ethical and legal compatibility
and compliance are certainly prerequisites. A carefully crafted framework for governance
of the various aspects of telemedicine will strengthen its adoption and lead to long-term
sustainability. Future research focusing on monitoring the quality of care delivered and the
impact of safety in telemedicine is needed. Given how technology has transformed our
everyday lives over the past few decades, it is inevitable that our healthcare landscape will
be equally influenced by it over time. Ultimately, no matter the format of interaction or the
method employed in accomplishing our clinical duties, we have a fiduciary responsibility
to act in the best interest of patients with due regard to their values and preferences.
Author Contributions: Conceptualization, S.H. and T.L.; writing—original draft preparation, S.H.,
T.C.V., H.C. and G.L.T.; writing—review and editing, S.H., T.C.V., H.C., G.L.T. and T.L.; visualization,
T.L. All authors have read and agreed to the published version of the manuscript.
Funding: This research received no external funding.
Conflicts of Interest: The authors declare no conflict of interest.
References
1.
2.
Tuckson, R.V.; Edmunds, M.; Hodgkins, M.L. Telehealth. N. Engl. J. Med. 2017, 377, 1585–1592. [CrossRef] [PubMed]
Institute of Medicine (US) Committee on Evaluating Clinical Applications of Telemedicine; Field, M.J. (Eds.) Telemedicine: A Guide
to Assessing Telecommunications in Health Care; National Academies Press: Washington, DC, USA, 1996.
Int. J. Environ. Res. Public Health 2022, 19, 5445
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
11 of 13
Dunn, E.V.; Conrath, D.W.; Bloor, W.G.; Tranquada, B. An evaluation of four telemedicine systems for primary care. Health Serv.
Res. 1977, 12, 19–29. [PubMed]
Bradford, N.K.; Caffery, L.J.; Smith, A.C. Telehealth services in rural and remote Australia: A systematic review of models of care
and factors influencing success and sustainability. Rural Remote Health 2016, 16, 3808. [PubMed]
Johnston, R.; Staveley, R.; Olfert, L.A.; Jennett, P. An industry, clinical, and academic telehealth partnership venture: Progress,
goals achieved, and lessons learned. Telemed. J. e-Health 2000, 6, 341–348. [CrossRef]
Flodgren, G.; Rachas, A.; Farmer, A.J.; Inzitari, M.; Shepperd, S. Interactive telemedicine: Effects on professional practice and
health care outcomes. Cochrane Database Syst. Rev. 2015, 9, CD002098. [CrossRef]
Boxer, R.J.; Ellimoottil, C. Advantages and utilization of telemedicine. mHealth 2019, 5, 12. [CrossRef]
Taylor, K. How Digital Technology Is Transforming Health and Social Care; Deloitte Centre for Health Solutions: London, UK, 2015.
Nittari, G.; Savva, D.; Tomassoni, D.; Tayebati, S.K.; Amenta, F. Telemedicine in the COVID-19 Era: A Narrative Review Based on
Current Evidence. Int. J. Environ. Res. Public Health 2022, 19, 5101. [CrossRef]
Lurie, N.; Carr, B.G. The Role of Telehealth in the Medical Response to Disasters. JAMA Intern. Med. 2018, 178, 745–746. [CrossRef]
Simmons, S.; Alverson, D.; Poropatich, R.; D’Iorio, J.; DeVany, M.; Doarn, C.R. Applying telehealth in natural and anthropogenic
disasters. Telemed. J. e-Health 2008, 14, 968–971. [CrossRef]
Smith, A.C.; Thomas, E.; Snoswell, C.L.; Haydon, H.; Mehrotra, A.; Clemensen, J.; Caffery, L.J. Telehealth for global emergencies:
Implications for coronavirus disease 2019 (COVID-19). J. Telemed. Telecare 2020, 26, 309–313. [CrossRef]
Hincapié, M.A.; Gallego, J.C.; Gempeler, A.; Piñeros, J.A.; Nasner, D.; Escobar, M.F. Implementation and Usefulness of
Telemedicine During the COVID-19 Pandemic: A Scoping Review. J. Prim. Care Community Health 2020, 11, 2150132720980612.
[CrossRef] [PubMed]
Colbert, G.B.; Venegas-Vera, A.V.; Lerma, E.V. Utility of telemedicine in the COVID-19 era. Rev. Cardiovasc. Med. 2020, 21, 583–587.
[PubMed]
Michel, J.; Mettler, A.; Müller, M.; Hautz, W.E.; Sauter, T.C. A Utility Framework for COVID-19 Online Forward Triage Tools: A
Swiss Telehealth Case Study. Int. J. Environ. Res. Public Health 2022, 19, 5184. [CrossRef]
Lai, S.H.S.; Tang, C.Q.Y. Telemedicine and COVID-19: Beyond just virtual consultations—The Singapore experience. Bone Jt.
Open 2020, 1, 203–204. [CrossRef]
Zhang, J.; Chua, Q.H.A.; Shen, X.M.; Viseikumaran, J.A.; Teoh, T.; Tan, N.G. A Systematic Implementation of Telemedicine in
Singapore’s COVID-19 Community Recovery Facilities. Telemed. J. e-Health 2022, in press. [CrossRef] [PubMed]
Chia, M.L.; Him Chau, D.H.; Lim, K.S.; Yang Liu, C.W.; Tan, H.K.; Tan, Y.R. Managing COVID-19 in a Novel, Rapidly Deployable
Community Isolation Quarantine Facility. Ann. Intern. Med. 2021, 174, 247–251. [CrossRef] [PubMed]
Ministry of Health Singapore. Vaccination Statistics. Available online: https://www.moh.gov.sg/covid-19/vaccination/statistics
(accessed on 21 April 2022).
Ministry of Health Continuation of Essential Healthcare Services during Period of Heightened Safe Distancing Measures.
Available online: https://www.moh.gov.sg/news-highlights/details/continuation-of-essential-healthcare-services-duringperiod-of-heightened-safe-distancing-measures (accessed on 8 March 2022).
Ministry of Health Annex A: Examples of Essential and Non-Essential Services. Available online: https://www.moh.gov.sg/
docs/librariesprovider5/pressroom/press-releases/annex-a3685da33172d4ed08bb310ec24a440f8.pdf (accessed on 8 March 2022).
Singapore Renal Registry Annual Report. National Registry of Disease Office. Available online: https://www.nrdo.gov.sg/docs/
librariesprovider3/default-document-library/srr-annual-report-2020.pdf?sfvrsn=658dd717_0 (accessed on 21 April 2022).
Singapore, M.O.H. Guidelines for Private Healthcare Institutions Providing Renal Dialysis: Regulation 4 of the Private Hospitals
or Medical Clinics Regulations [CAP 248, Rg 1]. 2001. Available online: https://www.moh.gov.sg/docs/librariesprovider5
/licensing-terms-and-conditions/guidelines-for-private-healthcare-institutions-providing-renal-dialysis.pdf (accessed on 3
March 2022).
Lew, S.Q.; Sikka, N. Operationalizing Telehealth for Home Dialysis Patients in the United States. Am. J. Kidney Dis. 2019, 74,
95–100. [CrossRef]
Lew, S.Q. Telehealth in Peritoneal Dialysis: Review of Patient Management. Adv. Perit. Dial. 2018, 34, 32–37.
Singapore, M.O.H. National Telemedicine Guidelines. 2015. Available online: https://www.moh.gov.sg/docs/librariesprovider5
/licensing-terms-and-conditions/national-telemedicine-guidelines-for-singapore-(dated-30-jan-2015).pdf (accessed on 3
March 2022).
Staines, A.; Amalberti, R.; Berwick, D.M.; Braithwaite, J.; Lachman, P.; Vincent, C.A. COVID-19: Patient safety and quality
improvement skills to deploy during the surge. Int. J. Qual. Health Care 2021, 33, mzaa050. [CrossRef]
Patient Safety Network. Telehealth and Patient Safety during the COVID-19 Response. 2020. Available online: https://www.
psnet.ahrq.gov/perspective/telehealth-and-patient-safety-during-covid-19-response (accessed on 21 April 2022).
Emanuel, L.; Berwick, D.; Conway, J.; Combes, J.; Hatlie, M.; Leape, L.; Reason, J.; Schyve, P.; Vincent, C.; Walton, M. What
Exactly Is Patient Safety? In Advances in Patient Safety: New Directions and Alternative Approaches; Henriksen, K., Battles, J.B.,
Keyes, M.A., Grady, M.L., Eds.; Agency for Healthcare Research and Quality: Rockville, MD, USA, 2008. Available online:
https://www.ncbi.nlm.nih.gov/books/NBK43629/ (accessed on 21 April 2022).
Vincent, C. Patient Safety; Elsevier: London, UK, 2006.
Int. J. Environ. Res. Public Health 2022, 19, 5445
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
12 of 13
Agarwal, A.K.; Sequeira, A.; Oza-Gajera, B.P.; Ramani, K.; Packer, J.; Litchfield, T.; Nations, M.L.; Lerma, E.V. Lessons learnt and
future directions in managing dialysis access during the COVID 19 pandemic: Patient and provider experience in the United
States. J. Vasc. Access 2021, in press. [CrossRef]
Lok, C.E.; Huber, T.S.; Lee, T.; Shenoy, S.; Yevzlin, A.S.; Abreo, K.; Allon, M.; Asif, A.; Astor, B.C.; Glickman, M.H.; et al. National
Kidney Foundation. KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. Am. J. Kidney Dis. 2020, 75 (Suppl. S2),
S1–S164. [CrossRef] [PubMed]
Haroon, S.; Lau, T.; Tan, G.L.; Davenport, A. Telemedicine in the Satellite Dialysis Unit: Is It Feasible and Safe? Front. Med. 2021,
8, 634203. [CrossRef] [PubMed]
Fleming, R.; Gartner, D.; Padman, R.; James, D. An Analytical Approach for Improving Patient-centric Delivery of Dialysis
Services. AMIA Annu. Symp. Proc. 2019, 2019, 418–427. [PubMed]
Singh, T.; Ngoh, C.L.; Wong, K.; Khan, B.A. Impact of Telemedicine on Hospitalisation and Mortality Rates in Community-Based
Haemodialysis Centres in Singapore during the COVID-19 Pandemic. Ann. Acad. Med. Singap. 2020, 49, 756–763. [CrossRef]
[PubMed]
Taylor, M.J.; McNicholas, C.; Nicolay, C.; Darzi, A.; Bell, D.; Reed, J.E. Systematic review of the application of the plan-do-study-act
method to improve quality in healthcare. BMJ Qual. Saf. 2014, 23, 290–298. [CrossRef] [PubMed]
Pham, J.C.; Hoffman, C.; Popescu, I.; Ijagbemi, O.M.; Carson, K.A. A Tool for the Concise Analysis of Patient Safety Incidents.
Jt. Comm. J. Qual. Patient Saf. 2016, 42, 26–33. [CrossRef]
Telehealth Consultant Satisfaction Survey. Available online: https://digital.ahrq.gov/sites/default/files/docs/survey/
telehealthconsultantsatisfactionsurvey_comp.pdf (accessed on 3 March 2022).
Utah Telehealth Network. Telehealth Patient Satisfaction Survey. Available online: https://digital.ahrq.gov/sites/default/files/
docs/survey/telehealthpatientsatisfactionsurvey_comp.pdf (accessed on 3 March 2022).
Kawaguchi, T.; Karaboyas, A.; Robinson, B.M.; Li, Y.; Fukuhara, S.; Bieber, B.A.; Rayner, H.C.; Andreucci, V.E.; Pisoni, R.L.; Port,
F.K.; et al. Associations of frequency and duration of patient-doctor contact in hemodialysis facilities with mortality. J. Am. Soc.
Nephrol. 2013, 24, 1493–1502. [CrossRef]
Singapore Medical Council. Ethical Code and Ethical Guidelines. 2016 Edition. Available online: https://www.
healthprofessionals.gov.sg/docs/librariesprovider2/guidelines/2016-smc-ethical-code-and-ethical-guidelines---(13sep1
6).pdf (accessed on 8 March 2022).
Goldstein, B.D. The precautionary principle also applies to public health actions. Am. J. Public Health 2001, 91, 1358–1361.
[CrossRef]
Fins, J.J.; Miller, F.G. Proportionality, pandemics, and medical ethics. Am. J. Med. 2020, 133, 1243–1244. [CrossRef]
Low, J.; Dujacquier, D.; Kaur, S. Roland Berger Report: Bridging the Digital Divide/Improving Digital Inclusion in Southeast Asia.
Available online: https://www.rolandberger.com/en/Insights/Publications/Bridging-the-digital-divide.html (accessed on 14
April 2022).
International Trade Commission. Singapore—Information and Telecommunications Technology. Available online: https:
//www.trade.gov/country-commercial-guides/singapore-information-and-telecommunications-technology (accessed on 4
April 2022).
Ladin, K.; Porteny, T.; Perugini, J.M.; Gonzales, K.M.; Aufort, K.E.; Levine, S.K.; Wong, J.B.; Isakova, T.; Rifkin, D.; Gordon, E.J.;
et al. Perceptions of telehealth vs in-person visits among older adults with advanced kidney disease, care partners, and clinicians.
JAMA Netw. Open 2021, 4, e2137193. [CrossRef]
Stauss, M.; Floyd, L.; Becker, S.; Ponnusamy, A.; Woywodt, A. Opportunities in the cloud or pie in the sky? Current status and
future perspectives of telemedicine in nephrology. Clin. Kidney J. 2021, 14, 492–506. [CrossRef] [PubMed]
Bhaskar, S.; Bradley, S.; Chattu, V.K.; Adisesh, A.; Nurtazina, A.; Kyrykbayeva, S.; Sakhamuri, S.; Yaya, S.; Sunil, T.; Thomas,
P.; et al. Telemedicine Across the Globe-Position Paper From the COVID-19 Pandemic Health System Resilience PROGRAM
(REPROGRAM) International Consortium (Part 1). Front. Public Health 2020, 8, 556720. [CrossRef] [PubMed]
Healthcare Services Act (HCSA). 2020. Available online: https://www.moh.gov.sg/hcsa/home (accessed on 8 March 2022).
Prabakaran, P. The Medico-Legal Dilemmas of the Regulation of Telemedicine and AI in Singapore’s Healthcare Context. Available
online: https://lawtech.asia/the-medico-legal-dilemmas-of-the-regulation-of-telemedicine-and-ai-in-singapores-healthcarecontext/ (accessed on 8 March 2022).
Regulatory Guideline for Telehealth Products. 2019. Available online: https://www.hsa.gov.sg/docs/default-source/hprg-mdb/
regulatory-guidelines-for-telehealth-products-rev-2-1.pdf (accessed on 8 March 2022).
Artificial Intelligence in Healthcare Guidelines (AIHGle). 2021. Available online: https://www.moh.gov.sg/docs/
librariesprovider5/eguides/1-0-artificial-in-healthcare-guidelines-(aihgle)_publishedoct21.pdf (accessed on 8 March 2022).
Guidelines for Telepharmacy 2009. Available online: https://www.pss.org.sg/sites/default/files/Guidelines/guidelines_for_
telepharmacy.pdf (accessed on 8 March 2022).
Health Products (Licensing of Retail Pharmacies) Regulations 2016. Available online: https://sso.agc.gov.sg/SL/HPA2007-S330
-2016 (accessed on 8 March 2022).
World Health Organization. Implementing Telemedicine Services during COVID-19: Guiding Principles and Considerations for a
Stepwise Approach. 2021. Available online: https://www.who.int/publications/i/item/WPR-DSE-2020-032 (accessed on 19
April 2022).
Int. J. Environ. Res. Public Health 2022, 19, 5445
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
13 of 13
Medical Registration Act 1997, s53(d). Available online: https://sso.agc.gov.sg/Act/MRA1997?ProvIds=P17-#pr53- (accessed on
8 March 2022).
Koh, E.Y.; Mak, W.M.; Tee, C.; Tham, H.H. COVID-19 and Issues Facing the Healthcare Community: How Can Telemedicine
Help? Allen & Gledhill, 23 April 2020.
Leveraging on Telemedicine during an Infectious Disease Outbreak. 2020. Available online: https://www.sma.org.sg/
UploadedImg/files/ncov2019/LeveragingTelemedicineInfectiousDiseaseOutbreak20200212.pdf (accessed on 8 March 2022).
Bolam v Friern Hospital Management Committee [1957] 1 WLR 582.
Bolitho v City and Hackney Health Authority [1998] AC 232.
Dr Khoo James & Anor v Gunapathy d/o Muniandy [2002] 2 SLR 414.
Price, W.N., II. Artificial Intelligence in Health Care: Applications and Legal Implications. SciTech Lawyer 2017, 14, 10–13.
Hii Chii Kok v Ooi Peng Jin London Lucien and Anor [2017] 2 SLR 492.
Civil Law (Amendment) Bill (No. 33/2020), s37. Available online: https://sso.agc.gov.sg/Bills-Supp/33-2020/Published/202009
03?DocDate=20200903 (accessed on 8 March 2022).
Leite, H.; Hodgkinson, I.R.; Gruber, T. New Development: ‘Healing at a Distance’—Telemedicine and COVID-19. Public Money
Manag. 2020, 40, 483–485. [CrossRef]
U.S. Department of Health & Human Services. Notification of Enforcement Discretion for Telehealth Remote Communications during the COVID-19 Nationwide Public Health Emergency. 2021. Available online: https://www.hhs.gov/hipaa/forprofessionals/special-topics/emergency-preparedness/notification-enforcement-discretion-telehealth/index.html (accessed on
19 April 2022).
Personal Data Protection Act 2012, ss2, 13 and 24. Available online: https://sso.agc.gov.sg/Act/PDPA2012? (accessed on 8
March 2022).
Wong, B. COVID-19 Response Measures and Data Protection Law in Singapore. Available online: https://nus-covaid.com/
academics-on-pandemics/covid-19-response-measures-and-data-protection-law-in-singapore-by-benjamin-wong (accessed on
19 April 2022).
Personal Data Protection Commission, Singapore. Advisories on Collection of Personal Data for COVID-19 Contact Tracing and
Use of SafeEntry. 2022. Available online: https://www.pdpc.gov.sg/Help-and-Resources/2021/05/Advisory-on-Collection-ofPersonal-Data-for-COVID-19-Contact-Tracing (accessed on 19 April 2022).
Singapore Health Services Pte. Ltd. & Ors, SGPDPC 3. 2019. Available online: https://www.pdpc.gov.sg/-/media/Files/PDPC/
PDF-Files/Commissions-Decisions/Grounds-of-Decision---SingHealth-IHiS---150119.pdf (accessed on 8 March 2022).
Aw, J.; Cheng, A.W.R. Medicine and the Law: Telemedicine (Part 2). SMA News 2021, 53, 12–13.